Search Results - "Levine, KM"

Abstract PD8-08: ESR1 mutations confer novel metastatic functions in genome-edited breast cancer cell models by Oesterreich, S, Li, Z, Bahreini, A, Wang, P, Levine, KM, Tasdemir, N, Chu, D, Park, BH, Lee, AV

“…Abstract Background: Estrogen receptor alpha (ERα), encoded by the ESR1 gene, is expressed in approximately 70% of breast cancers. Recent studies conducted by…”
Get full text

Abstract P1-03-03: Invasive lobular carcinoma and invasive ductal carcinoma differ in immune response, translation efficiency and metabolic rate by Levine, KM, Du, T, Zhu, L, Tasdemir, N, Lee, AV, Van Houten, B, Tseng, GC, Oesterreich, S

“…Abstract Background Invasive lobular carcinoma (ILC) is the second most common histological subtype of breast cancer after invasive ductal carcinoma (IDC). ILC…”
Get full text

Abstract P5-04-21: FGFR4 is a novel druggable target for recurrent ER-positive breast cancers by Levine, KM, Ding, K, Priedigkeit, N, Sikora, MJ, Tasdemir, N, Zhu, L, Tseng, GC, Jankowitz, RC, Dabbs, DJ, McAuliffe, PF, Lee, AV, Oesterreich, S

“…Abstract Background Breast cancer recurrence is a major clinical problem for estrogen receptor positive (ER+) disease, even decades after initial surgery…”
Get full text

Abstract PD4-09: Combination FGFR4 and ER-targeted therapy for invasive lobular carcinoma by Levine, KM, Chen, J, Sikora, MJ, Tasdemir, N, Priedigkeit, N, Tseng, GC, Puhalla, SL, Jankowitz, RC, Dabbs, DJ, McAuliffe, PF, Lee, AV, Oesterreich, S

“…Abstract Background Invasive Lobular Carcinoma (ILC) is an understudied subtype of breast cancer that requires novel therapies in the advanced setting…”
Get full text

Abstract P4-05-02: Differential regulation of ER protein-turnover in invasive lobular carcinoma cells by Jankowitz, RC, Sreekumar, S, Levine, KM, Meier, C, Sikora, MJ, Basudan, A, Boone, D, Dabbs, DJ, Jacobsen, B, Lee, AV, Oesterreich, S

“…Abstract Background: Invasive lobular breast carcinoma (ILC) accounts for 10-15% of breast cancers diagnosed annually. ILCs are more likely to be positive…”
Get full text

Abstract P2-01-09: ESR1 mutations drive breast cancer metastasis by context-dependent alterations in adhesive and migratory properties by Li, Z, Bahreini, A, Levine, KM, Wang, P, Tasdemir, N, Montanez, MA, Sundd, P, Wallace, CT, Watkins, SC, Chu, D, Park, BH, Hou, W, Mooring, MS, Zhu, L, Tseng, GC, Carroll, JS, Atkinson, JM, Lee, AV, Oesterreich, S

“…Abstract Background: Estrogen receptor alpha (ERα/ESR1) is mutated in 30-40% of endocrine resistant ER+ breast cancer. These mutations, primarily located in…”
Get full text

Abstract PD7-03: Investigating cortactin as a genetic driver of disease progression in invasive lobular carcinoma by Tasdemir, N, Sikora, MJ, Zhu, L, Levine, KM, Scott, J, Basudan, A, Sflomos, G, Sreekumar, S, Bossart, EA, Elishaev, E, Chandran, UR, Tseng, GC, Jankowitz, RC, Dabbs, DJ, McAuliffe, PF, Brisken, C, Davidson, NE, Oesterreich, S

“…Abstract Invasive lobular carcinoma (ILC) is the second most common type of breast cancer following invasive ductal carcinoma (IDC) and accounts for 10-15% of…”
Get full text

Unpaid expert witnesses by Levine, K M

Get full text

Contingent tutoring of long-division skills in fourth and fifth graders: Experimental tests of some hypotheses about scaffolding by Pratt, Michael W., Savoy-Levine, Kathy M.

“…In two studies, the type of instruction to which children were exposed was manipulated, in order to study the effectiveness of “contingent” instructional…”
Get full text